Ernest Nadal

10.3k citations

169 papers · 3.6k indexed · 1 hit paper · h-index 34

Impact in

Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in

Pulmonary and Respiratory Medicine 124
- Lung Cancer Treatments and Mutations 91
- Lung Cancer Diagnosis and Treatment 28
- Brain Metastases and Treatment 14
Oncology 93
- Lung Cancer Research Studies 34
- Cancer Immunotherapy and Biomarkers 33
- Colorectal Cancer Treatments and Studies 21

Co-authors: Enriqueta Felip David G. Beer Alberto Villanueva Andrew C. Chang Jules Lin Jordi Bruna Christian Rolfo Marta Román
Journals: Annals of Oncology (27 papers)Journal of Clinical Oncology (21 papers)Journal of Thoracic Oncology (19 papers)Lung Cancer (10 papers)Clinical Cancer Research (6 papers)
Partner nations: Spain United States France

In The Last Decade

Ernest Nadal

152 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial 2022 · 144 citations

Peers

Countries citing papers authored by Ernest Nadal

Since Specialization

Citations

This map shows the geographic impact of Ernest Nadal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Nadal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Nadal more than expected).

Fields of papers citing papers by Ernest Nadal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Nadal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Nadal. The network helps show where Ernest Nadal may publish in the future.

Co-authors

The 25 scholars most cited alongside Ernest Nadal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ernest Nadal Line = papers co-authored together Ernest Nadal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract CT249: Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy Cancer Research ·Charu Aggarwal, James Stevenson, Dariusz M. Kowalski, Tibor Csőszi, Nir Peled, Byoung Chul Cho, Belén Rubio‐Viqueira, Jiaxin Niu, David P. Carbone, Susanne M. Arnold, Mark M. Awad, Justin F. Gainor, Suman Rao, Anne S. Tsao, Heng Zhou, Omobolaji O. Akala, Elliot Chartash, Ernest Nadal	2024	1
2	Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis Journal of Medical Economics ·Dolores Isla, Rosa Álvarez, María José Domper-Arnal, Edurne Arriola, Aitor Azkárate, Eider Azkona, Rosario García-Campelo, Pilar Garrido, Ernest Nadal, Ana Laura Ortega Granados, David Carcedo, María J. Crespo, Jesús Lavara, Fernando Córcoles, Reyes Bernabé	2024	3
3	Intracranial outcomes of 1L selpercatinib in advanced RET fusion-positive NSCLC: LIBRETTO-431 study. Journal of Clinical Oncology ·M. Pérol, Kōichi Goto, Benjamin Solomon, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Martín, Jair Bar, Justin N. Williams, Tarun Puri, Li J, M. Uh, Boris K. Lin, Caicun Zhou	2024	0
4	Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment Cancers ·Laia Lorenzo-Esteller, Raúl Ramos-Polo, Alexandra Pons Riverola, Herminio Morillas, Javier Berdejo, Sònia Pernas, Helena Pomares, L. Asiáin, Alberto Garay, E. Martínez Pérez, Santiago Jiménez‐Marrero, L Alcoberro, Ernest Nadal, Paula Gubern-Prieto, Francisco Gual‐Capllonch, Encarna Hidalgo, Cristina Enjuanes, Josep Comín‐Colet, Pedro Moliner	2024	8
5	1269P Preventing infusion-related reactions with intravenous amivantamab: Updated results from SKIPPirr, a phase II study Annals of Oncology ·L.G. Paz-Ares, A.I. Spira, Han Jy, J-Y. Shih, Céline Mascaux, Upal Basu Roy, J. Zugazagoitia, Youn Joong Kim, C.H. Chiu, Seong‐Woo Kim, Ernest Nadal, (unknown), Parthiv J. Mahadevia, B. Anderson, Keyu Xia, G. Wang, Joshua Bauml, M. Chioda, Jorge Simões, G. Lopes	2024	4
6	CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non–Small Cell Lung Cancer Journal of Clinical Oncology ·M. Pérol, Benjamin Solomon, Kōichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Martín, Jair Bar, Justin N. Williams, Tarun Puri, Li J, Minji K. Uh, Boris K. Lin, Caicun Zhou	2024	5
7	#3789 SERUM AND URINARY SOLUBLE PD-1, PD-L1 AND PD-L2 AS BIOMARKERS FOR CHECKPOINT INHIBITOR RELATED ACUTE INTERSTITIAL NEPHRITIS Nephrology Dialysis Transplantation ·F.J. Gíl Gómez, Laura Martínez Valenzuela, Paula Antón Pampols, Marina Gomez-Tena, Montserrat Gomà‐i‐Freixanet, Ana Melissa Rau Lertora, Belén Rubio Rodríguez, Ernest Nadal, Maria Jové, Xavier Fulladosa, Josep María Cruzado, Joan Torras Ambrós, Juliana Draibe	2023	1
8	CN72 Symptom burden, quality of life and emotional status of patients with advanced lung cancer seen at the functional lung unit Annals of Oncology ·Brao Perez, M. Arellano, Cristina Lasmarías, Susana Padrones Sánchez, Ernest Nadal, Ramón Palmero, Maria Jove Casulleras, Jesús Brenes, M.A. Mosteiro Lamas, J. Saldaña Cañada, R.A. Portolés	2023	1
9	1358P Safety of tepotinib + EGFR TKI (osimertinib or gefitinib) in patients with EGFRm NSCLC Annals of Oncology ·Ernest Nadal, T.M. Kim, Valentina Guarneri, P.J. Voon, Boon Khaw Lim, Marie Wislez, Cheng Huang, Chong Kin Liam, Julien Mazières, Lye Mun Tho, Hidetoshi Hayashi, Nguyen Viet Nhung, Puey Ling Chia, Filippo de Marinis, Sabine Brutlach, Svenja Adrian, Barbara Ellers‐Lenz, Karin Berghoff, Niki Karachaliou, Yi‐Long Wu	2023	1
10	Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans Disease Models & Mechanisms ·Carmen Martínez-Fernández, M.A. Bergamino, Alfonso Schiavi, David Brena, Natascia Ventura, Sebastian Honnen, Alberto Villanueva, Ernest Nadal, Julián Cerón	2022	4
11	Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification Journal for ImmunoTherapy of Cancer ·Ania Alay, David Cordero, Sara Hijazo‐Pechero, Elisabet Aliagas, Adriana López‐Doriga, Raúl Marín, Ramón Palmero, Roger Llatjós, Ignacio Escobar, Ricard Ramos, Susana Padrones, Vı́ctor Moreno, Ernest Nadal, Xavier Solé	2021	16
12	RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non–Small Cell Lung Cancer Clinical Cancer Research ·Kazuhiko Nakagawa, Ernest Nadal, Edward B. Garon, Makoto Nishio, Takashi Seto, Nobuyuki Yamamoto, Keunchil Park, Jin‐Yuan Shih, Luis Paz‐Ares, Bente Frimodt‐Moller, Annamaria H. Zimmermann, Sameera R. Wijayawardana, Carla Visseren‐Grul, Martin Reck, (unknown)	2021	29
13	Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells Proceedings of the National Academy of Sciences ·Franziska Püschel, Francesca Favaro, Jaime Redondo-Pedraza, Estefanía Lucendo, Raffaella Iurlaro, Sandrine Marchetti, Blanca Majem, Eric Eldering, Ernest Nadal, Jean‐Ehrland Ricci, Éric Chevet, Cristina Muñoz‐Pinedo	2020	74
14	Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin Disease Models & Mechanisms ·Francisco J. García-Rodríguez, Carmen Martínez-Fernández, David Brena, Dmytro Kukhtar, Xènia Serrat, Ernest Nadal, Mike Boxem, Sebastian Honnen, Antonio Miranda–Vizuete, Alberto Villanueva, Julián Cerón	2018	15
15	MET -Oncogenic and JAK2 -Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer Clinical Cancer Research ·Maria Saigí, Juan J. Alburquerque-Béjar, Anne Mc Leer‐Florin, Carolina Pereira, Eva Pros, Octavio A. Romero, Núria Baixeras, Anna Esteve‐Codina, Ernest Nadal, Élisabeth Brambilla, Montse Sánchez‐Céspedes	2018	75
16	A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer Clinical Cancer Research ·Ángel Díaz‐Lagares, Jesús Méndez‐González, David Hervás, Maria Saigí, María J. Pajares, Diana Garcia, Ana B. Crujerias, Rubén Pı́o, Luis M. Montuenga, Javier J. Zulueta, Ernest Nadal, Antoni Rosell, Manel Esteller, Juan Sandoval	2016	103
17	A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma Clinical Cancer Research ·Ernest Nadal, Jinjie Zhong, Jules Lin, Rishindra M. Reddy, Nithya Ramnath, Mark B. Orringer, Andrew C. Chang, David G. Beer, Guoan Chen	2014	85
18	Modeling Lung Cancer Evolution and Preclinical Response by Orthotopic Mouse Allografts Cancer Research ·Chiara Ambrogio, Francisco javier García Carmona, August Vidal, Mattia Falcone, Patricia Nieto, Octavio A. Romero, Sara Puertas, Miguel Vizoso, Ernest Nadal, Teresa Poggio, Montse Sánchez‐Céspedes, Manel Esteller, Francisca Mulero, Claudia Voena, Roberto Chiarle, Mariano Barbacid, David Santamarı́a, Alberto Villanueva	2014	18
19	Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma Clinical Cancer Research ·Ernest Nadal, Guoan Chen, Marc Gallegos, Lin Lin, Daysha Ferrer-Torres, Anna Truini, Zhuwen Wang, Jules Lin, Rishindra M. Reddy, Roger Llatjós, Ignacio Escobar, Juan Moya, Andrew C. Chang, Felipe Cardenal, Gabriel Capellá, David G. Beer	2013	53
20	Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer Cancer Epidemiology Biomarkers & Prevention ·Rubén Pı́o, Javier García, Leticia Corrales, Daniel Ajona, Michael Fleischhacker, María J. Pajares, Felipe Cardenal, Luis Seijó, Javier J. Zulueta, Ernest Nadal, Christian Witt, María D. Lozano, Bernd Schmidt, Luis M. Montuenga	2010	27

About Ernest Nadal

Ernest Nadal is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Aging and Geriatrics and Gerontology, having authored 169 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (91 papers), Lung Cancer Research Studies (34 papers), Cancer Immunotherapy and Biomarkers (33 papers), Cancer Genomics and Diagnostics (30 papers), Lung Cancer Diagnosis and Treatment (28 papers), Colorectal Cancer Treatments and Studies (21 papers), Brain Metastases and Treatment (14 papers) and RNA modifications and cancer (11 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (815 citations), Molecular Biology (1.5k citations) and Immunology (361 citations). Ernest Nadal has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Enriqueta Felip, David G. Beer, Alberto Villanueva, Andrew C. Chang, Jules Lin, Jordi Bruna, Christian Rolfo, Marta Román, Silvestre Vicent and Iosune Baraibar. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact